The USPTO’s recent guidance on AI usage marks a critical moment for legal practitioners. This document emphasizes the necessity for both technical and human oversight in mitigating the risks associated with AI tools. The agency is committed to leveraging AI’s benefits across society while ensuring that these technologies do not compromise the integrity of legal processes.
The
Continue Reading Embracing AI in Patent Law: Navigating the USPTO’s Latest GuidanceSeyfarth Synopsis: In 2022, the Federal Circuit definitively ruled that artificial intelligence (AI) systems cannot be named inventors or co-inventors on patent applications, reinforcing the longstanding principle that only natural persons are eligible as inventors under the Patent Act. This decision, however, left an important question unanswered: Are inventions created with AI assistance patentable?
Today, the United
Continue Reading USPTO Guidelines Define the Role of AI in Patent InventorshipBy Tonya M. Esposito, Renee B. Appel, and Jonathan Huie
Seyfarth Synopsis: CBD is “thriving” in the current regulatory environment, but is it doing so illegally?
As former U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb opined last week, “the CBD craze is getting out of hand. The FDA needs to act.” Since the passage
Continue Reading CBD is Everywhere – But Where Does the FDA Stand?
By Becki Lee
Seyfarth Synopsis: Regular readers will recall that in March we blogged about cannabis-related trademarks. We now have an update:
On May 2, 2019, the USPTO distributed an Examination Guide updating their practices after passage of the 2018 Farm Bill on December 20, 2018. The Farm Bill removes “hemp” from the definition of “marijuana” in the
Continue Reading Likely to be Dazed and Confused – An Update